Release Date: December 5, 2025
Expiration Date: December 5, 2026
Activity Overview
This educational activity is an archive of the live presentation held on November 12-14, 2025.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is intended for oncologists, hematologists, nurses, advanced practice providers, pharmacists, radiotherapists, immunologists, fellows, researchers, pathologists, and other health care professionals involved in or interested in the treatment and management of patients with cancer, including solid tumors and hematologic malignancies.
Learning Objectives
Upon successful completion of this activity, learners will be better able to:
- Describe the supporting evidence for novel biomarker-testing approaches that guide the use of targeted therapies and/or modification of treatment plans
- Evaluate efficacy and safety data from recent pivotal trials investigating new and emerging therapies
- Develop personalized treatment plans based on evolving evidence, guideline recommendations, and individual patient/disease characteristics
- Apply strategies to identify and mitigate treatment-related adverse effects associated with novel therapies and combination regimens
Benjamin P. Levy, MD
Associate Professor of Oncology
Johns Hopkins University School of Medicine
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Sibley Memorial Hospital
Washington, DC
John O. Mascarenhas, MD
Director, Center of Excellence in Blood Cancers and
Myeloid Disorders
Professor of Medicine
Icahn School of Medicine at Mount Sinai
The Tisch Cancer Institute
New York, NY
Tiffany A. Traina, MD, FASCO
Associate Attending Physician
Vice Chair, Oncology; Department of Medicine
Section Head, Triple Negative Breast Cancer Clinical
Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medicine
New York, NY
Full faculty information and disclosures are available by reviewing the program workbook, linked here.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, (PER®) have no relevant financial relationships with ineligible companies.
PER mitigated all COI for faculty, staff, and planners prior to the start of this activity.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here